16,176 results on '"mesothelioma"'
Search Results
2. Individualized Response Assessment to Heated Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Peritoneal Carcinomatosis From Ovarian, Colorectal, Appendiceal, or Peritoneal Mesothelioma Histologies
3. Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing (BASECAMP-1)
4. A Study to Evaluate the Safety and Efficacy of A2B694, a Logic-gated CAR T, in Subjects With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression (EVEREST-2)
5. Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
6. MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma (eVOLVE-Meso)
7. A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
8. Intra-pleural Administration of GL-ONC1, a Genetically Modified Vaccinia Virus, in Patients With Malignant Pleural Effusion: Primary, Metastases and Mesothelioma
9. SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
10. Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma
11. Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
12. HIPEC for Peritoneal Carcinomatosis
13. A Study of SGN-MesoC2 in Advanced Solid Tumors
14. A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Cancer or Mesothelioma (Pegathor Lung 202)
15. Immune Microenvironment and Gene Expression Profiling in Mesothelioma (Imaging-Meso)
16. Olaparib in Patients With HRD Malignant Mesothelioma
17. Atezolizumab and Bevacizumab in Treating Patients with Rare Solid Tumors
18. Phase 1 Dose Escalation and Expansion to Evaluate AROG4-01 in Patients with Advanced Solid Tumors (CLINBERMES)
19. Long Term Follow-up of Mesothelioma Patients and Their Family Members With Germline Mutations in BAP1 and Other Genes
20. Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)
21. Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin
22. Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma
23. Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types
24. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors
25. A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors
26. Agnostic Therapy in Rare Solid Tumors (ANTARES)
27. Hemithoracic Irradiation With Proton Therapy in Malignant Pleural Mesothelioma (HIT-Meso)
28. Identification of Prognostic and Predictive Biomarkers of Toxicity in Patients With Malignant Pleural Mesothelioma and Treated With High Doses of Radiotherapy (MESORTIBO) (MESORTIBO)
29. SW-682 in Advanced Solid Tumors
30. Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors
31. Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders
32. PRO1184 for Advanced Solid Tumors (PRO1184-001)
33. Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma
34. Rapid Autopsy and Procurement of Cancer Tissue
35. Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels
36. Study of CAR.70-engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Advanced Renal Cell Carcinoma, Mesothelioma and Osteosarcoma
37. Galinpepimut-S (WT-1 Analog Peptide) Vaccine in Malignant Pleural Mesothelioma After Combined Modality Therapy
38. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors
39. Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies
40. A Study to Assess the Long-term Safety of Tazemetostat (TRuST)
41. Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients with PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior Therapies (MESOVAX)
42. Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome
43. A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors
44. Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
45. NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
46. Pembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural Mesothelioma
47. Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma
48. A Study of VET3-TGI in Patients With Solid Tumors (STEALTH-001)
49. TTFields in General Routine Clinical Care in Patients with Pleural Mesothelioma Study (TIGER Meso)
50. Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment (Pemetrexed and Cisplatin [or Carboplatin]) for Stage I-IIIA Malignant Pleural Mesothelioma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.